SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000919574-18-004395
Filing Date
2018-06-27
Accepted
2018-06-27 17:23:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 d7936818_13d-a.htm SC 13D/A 150807
  Complete submission text file 0000919574-18-004395.txt   152546
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Subject) CIK: 0001211583 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-80470 | Film No.: 18922579
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 3 WEST HILL PLACE BOSTON MA 02114
Business Address 3 WEST HILL PLACE BOSTON MA 02114 617-399-1740
MANCHESTER MANAGEMENT PR, LLC (Filed by) CIK: 0001735534 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A